Literature DB >> 6369295

Cystic fibrosis.

M E Hodson.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6369295      PMCID： PMC2417767          DOI： 10.1136/pgmj.60.701.225

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  42 in total

1.  Bronchial lability in cystic fibrosis.

Authors:  G Day; M B Mearns
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

2.  Prenatal detection of cystic fibrosis.

Authors:  H L Nadler; P Rembelski; K H Mesirow
Journal:  Lancet       Date:  1981-11-28       Impact factor: 79.321

3.  Monospecific antisera, hybridoma antibodies, and immunoassays for cystic fibrosis protein.

Authors:  G B Wilson
Journal:  Lancet       Date:  1980-08-09       Impact factor: 79.321

4.  PABA screening test for exocrine pancreatic function in infants and children.

Authors:  M Sacher; A Kobsa; D H Shmerling
Journal:  Arch Dis Child       Date:  1978-08       Impact factor: 3.791

5.  The sweat test: sodium and chloride values.

Authors:  H Shwachman; A Mahmoodian; R K Neff
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

6.  The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups.

Authors:  C W Bedrossian; S D Greenberg; D B Singer; J J Hansen; H S Rosenberg
Journal:  Hum Pathol       Date:  1976-03       Impact factor: 3.466

7.  Cystic fibrosis in adolescents and adults.

Authors:  P Mitchell-Heggs; M Mearns; J C Batten
Journal:  Q J Med       Date:  1976-07

8.  Cystic fibrosis: survival to adult life: ability to live with disability.

Authors:  J L Allan; P D Phelan
Journal:  Med J Aust       Date:  1980-06-14       Impact factor: 7.738

9.  Hypogammaglobulinemia in patients with cystic fibrosis.

Authors:  W J Matthews; M Williams; B Oliphint; R Geha; H R Colten
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

10.  Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.

Authors:  M E Hodson; H J Wingfield; J C Batten
Journal:  Br J Dis Chest       Date:  1983-01
View more
  6 in total

1.  Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations.

Authors:  A M Whitehead
Journal:  Pharm Weekbl Sci       Date:  1988-02-19

2.  Surgical management of pneumothorax in cystic fibrosis.

Authors:  D J Seddon; M E Hodson
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

Review 3.  Heart-lung transplantation for end-stage respiratory disease in cystic fibrosis patients.

Authors:  J P Scott; C Dennis; P Mullins
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

4.  Wasting as an independent predictor of mortality in patients with cystic fibrosis.

Authors:  R Sharma; V G Florea; A P Bolger; W Doehner; N D Florea; A J Coats; M E Hodson; S D Anker; M Y Henein
Journal:  Thorax       Date:  2001-10       Impact factor: 9.139

5.  Quality of life in adults with cystic fibrosis.

Authors:  J Congleton; M E Hodson; F Duncan-Skingle
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

6.  Sarcoidosis in two patients with cystic fibrosis: a fortuitous association?

Authors:  T J Cooper; A J Day; P H Weller; D M Geddes
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.